Invesco vs AbbVie

About

Invesco Ltd. is an Atlanta, Georgia-based global investment management company — publicly traded on the New York Stock Exchange (NYSE: IVZ) as an S&P 500 Financials component — managing approximately $1.85 trillion in assets under management across active equity, fixed income, multi-asset, and passive ETF strategies for institutional investors, financial advisors, and individual investors in more than 120 countries through approximately 8,400 employees. Invesco's most distinctive asset is the Invesco QQQ Trust (ticker: QQQ) — the world's most actively traded ETF, tracking the Nasdaq-100 index with $300B+ in assets and $100B+ in daily trading volume — which generates management fee revenue, brand recognition, and investor relationship access that no competitor outside BlackRock's iShares can match at that asset scale. In Q1 2025, Invesco reported earnings per share of $0.44 (beating analyst estimates of $0.40), revenue of $1.53 billion (beating expectations by $420 million), $17.6 billion in long-term net asset inflows representing 5.3% annualized growth, and adjusted operating margin expansion of more than 330 basis points year-over-year. CEO Andrew Schlossberg, who assumed leadership in 2023, has focused on operating efficiency and active ETF product development to compete with larger asset managers. Invesco acquired OppenheimerFunds from MassMutual in 2019 for $5.7 billion, expanding active equity capabilities and adding $228 billion in managed assets at the time.